Journal of Hematology Oncology Pharmacy

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

JHOP Print Edition

JHOP Weekly e-Newsletter

I have reviewed and consent to the terms of JHOP's Privacy Policy, and JHOP has my permission to retain my information in its database, and to forward pertinent communications to me.

Featured Articles

Original Article, Adverse Events

Safety and Efficacy of Intravenous Bisphosphonates for the Treatment of Hypercalcemia in Patients with Cancer and Baseline Renal Dysfunction

Original Article, Adverse Events, Oral Therapy

The Link Between Hypoalbuminemia and Oral Tyrosine Kinase Inhibitor Adverse Events in Adults with Malignant Solid Tumors

Original Article, Prostate Cancer, Genitourinary Cancers, Targeted Therapies

Comparing the Impact of Abiraterone and Enzalutamide Sequencing on Progression-Free Survival in Veterans with Metastatic Castration-Resistant Prostate Cancer

Editorial

Optimal Sequencing of Cancer Treatments an Increasingly Important Question

Practical Issues in Pharmacy Management

Sterility of Single-Use Vials When Using a Closed-System Transfer Device

Case Reports, Lung Cancer

Third-Line Tyrosine Kinase Inhibitor Therapy Results in 16-Year Remission in a Patient with Stage IV Non–Small-Cell Lung Cancer

FDA Oncology Update

Xalkori Now FDA Approved for the Treatment of ALK-Positive Inflammatory Myofibroblastic Tumor

Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma

Tafinlar plus Mekinist First Tumor Agnostic Therapy Approved for Any Unresectable or Metastatic Solid Tumors with BRAF Mutation

FDA Issues New Warning for Copiktra About Increased Risks for Serious Side Effects and Mortality

Talquetamab, First-in-Class Bispecific Monoclonal Antibody, Granted Breakthrough Therapy by the FDA for Relapsed or Refractory Multiple Myeloma

Meeting Highlights

PD-1 Inhibition with Dostarlimab Led to Remission in All Patients with Mismatch Repair-Deficient Rectal Cancer

Black Patients with Cancer and COVID-19 More Likely Than White Patients to Have Therapy Disruptions

Trastuzumab Deruxtecan a New Standard for Patients with HER2-Low Metastatic Breast Cancer

Patients Aged ≥55 Years with Luminal A Breast Cancer Can Safely Avoid Radiation

ASCO Highlights Innovation as Key to Equitable Cancer Care